{
"NDC": {
"NDCCode": "68788-4189-3",
"PackageDescription": "355 mL in 1 BOTTLE (68788-4189-3) ",
"NDC11Code": "68788-4189-03",
"ProductNDC": "68788-4189",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Geri-lanta Maximum Strength",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Aluminum Hydroxide, Magnesium Hydroxide, Dimethicone",
"DosageFormName": "SUSPENSION",
"RouteName": "ORAL",
"StartMarketingDate": "20000101",
"EndMarketingDate": null,
"MarketingCategoryName": "OTC MONOGRAPH DRUG",
"ApplicationNumber": "M001",
"LabelerName": "Preferred Pharmaceuticals Inc.",
"SubstanceName": "ALUMINUM HYDROXIDE; MAGNESIUM HYDROXIDE; DIMETHICONE, UNSPECIFIED",
"StrengthNumber": "400; 400; 40",
"StrengthUnit": "mg/5mL; mg/5mL; mg/5mL",
"Pharm_Classes": "Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2026-08-28",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260827",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}